دورية أكاديمية
Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?
العنوان: | Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST? |
---|---|
المؤلفون: | Abel, Mary Kathryn, Melisko, Michelle E., Rugo, Hope S., Chien, A. Jo, Diaz, Italia, Levine, Julia K., Griffin, Ann, McGuire, Joseph, Esserman, Laura J., Borno, Hala T., Mukhtar, Rita A. |
المصدر: | npj Breast Cancer ; volume 7, issue 1 ; ISSN 2374-4677 |
بيانات النشر: | Springer Science and Business Media LLC |
سنة النشر: | 2021 |
مصطلحات موضوعية: | Pharmacology (medical), Radiology, Nuclear Medicine and imaging, Oncology |
الوصف: | Enrollment in metastatic breast cancer trials usually requires measurable lesions, but patients with invasive lobular carcinoma (ILC) tend to form diffuse disease. We found that the proportion of patients with metastatic ILC enrolled in clinical trials at our institution was significantly lower than that of patients with invasive ductal carcinoma (IDC). Possible links between requiring measurable disease and decreased enrollment of ILC patients require further study to ensure equitable trial access. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
DOI: | 10.1038/s41523-021-00348-z |
الإتاحة: | https://doi.org/10.1038/s41523-021-00348-zTest https://www.nature.com/articles/s41523-021-00348-z.pdfTest https://www.nature.com/articles/s41523-021-00348-zTest |
حقوق: | https://creativecommons.org/licenses/by/4.0Test ; https://creativecommons.org/licenses/by/4.0Test |
رقم الانضمام: | edsbas.904C6083 |
قاعدة البيانات: | BASE |
DOI: | 10.1038/s41523-021-00348-z |
---|